Over 800 Cleansweep Auctions End Tomorrow 05/07 - Bid Now
Over 850 Total Lots Up For Auction at Four Locations - NJ Cleansweep 05/08, CA 05/09, CO 05/12, PA 05/15

Siemens and Massachusetts General Hospital Develop Prototype 128-Channel MRI System Based on Tim Technology

by Amanda Naiman, Manager, Media Relations, Siemens Medical Solutions | May 10, 2006

Suited for routine clinical and research use of all organs and body regions, the MAGNETOM Trio with Tim offers access to new applications, including abdominal, cardiac, spine, whole-body, and orthopedic MRI at 3T. Offering iPAT (integrated Parallel Acquisition Techniques), the industry's only complete high-speed Parallel Imaging package with syngo(R) GRAPPA and syngo SENSE, MAGNETOM Trio with Tim is the first generation of 3T whole-body systems that addresses potential challenges common with other 3T systems, and does so without image or workflow compromises.

Siemens Medical Solutions of Siemens AG (NYSE:SI) with headquarters in Malvern, Pennsylvania, and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Employing approximately 33,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.6 billion EUR, orders of 8.6 billion EUR and group profit of 976 million EUR for fiscal 2005. More information can be obtained by visiting www.usa.siemens.com/medical-pressroom.

stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats

* The information about this product is preliminary. The product is under development and not commercially available in the U.S. and its future availability cannot be ensured.


Back to HCB News